1. Home
  2. CPBI vs HYFT Comparison

CPBI vs HYFT Comparison

Compare CPBI & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Plains Bancshares Inc.

CPBI

Central Plains Bancshares Inc.

HOLD

Current Price

$18.38

Market Cap

73.5M

Sector

N/A

ML Signal

HOLD

HYFT

MindWalk Holdings Corp.

SELL

Current Price

$1.76

Market Cap

71.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CPBI
HYFT
Founded
2023
1983
Country
United States
United States
Employees
N/A
102
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.5M
71.9M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
CPBI
HYFT
Price
$18.38
$1.76
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
4.9K
448.7K
Earning Date
06-12-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.80
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$29.18
P/E Ratio
$22.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.52
$0.99
52 Week High
$18.75
$3.00

Technical Indicators

Market Signals
Indicator
CPBI
HYFT
Relative Strength Index (RSI) 63.80 69.74
Support Level $16.88 $1.56
Resistance Level N/A $1.93
Average True Range (ATR) 0.17 0.16
MACD 0.09 0.05
Stochastic Oscillator 74.29 72.15

Price Performance

Historical Comparison
CPBI
HYFT

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Share on Social Networks: